Arzumanyan A, Friedman T, Ng IO, Clayton MM, Lian Z, Feitelson MA: Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res 2011, 71: 3701-3708. doi:10.1158/0008-5472.CAN-10-3951
Article
Google Scholar
Bedossa P, Paynard T: An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996, 24: 289-293. 10.1002/hep.510240201
Article
Google Scholar
Cao D, Guo S, Allan RW, Molberg KH, Peng Y: SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009, 33: 894-904. doi:10.1097/PAS.0b013e318198177d
Article
Google Scholar
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127: 2893-2917. doi:10.1002/ijc.25516
Article
Google Scholar
Gonzalez-Roibon N, Katz B, Chaux A, Sharma R, Munari E, Faraj SF, Illei PB, Torbenson M, Netto GJ: Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. Hum Pathol 2013, 44: 1293-1299. doi:10.1016/j.humpath.2012.10.017
Article
Google Scholar
Guerrieri F, Belloni L, Pediconi N, Levrero M: Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis 2013, 33: 147-156. doi:10.1055/s-0033-1345721
Article
Google Scholar
Han SX, Wang JL, Guo XJ, He CC, Ying X, Ma JL, Zhang YY, Zhao Q, Zhu Q: Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma. J Immunol Res 2014, 2014: 262385. doi:10.1155/2014/262385
Google Scholar
Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR: Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008, 359: 1995-2004. doi:10.1056/NEJMoa0804525
Article
Google Scholar
Hoshida Y, Moeini A, Alsinet C, Kojima K, Villanueva A: Gene signatures in the management of hepatocellular carcinoma. Semin Oncol 2012, 39: 473-485. doi:10.1053/j.seminoncol.2012.05.003
Article
Google Scholar
Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, Takayasu K, Nakanuma Y, Makuuchi M, Matsuyama Y, Monden M, Kudo M: Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 2007, 37: 676-691. 10.1111/j.1872-034X.2007.00119.x
Article
Google Scholar
Kanda Y: Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013, 48: 452-458. doi:10.1038/bmt.2012.244
Article
Google Scholar
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41: 1313-1321. 10.1002/hep.20701
Article
Google Scholar
Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS: A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006, 12: 410-416. 10.1038/nm1377
Article
Google Scholar
Liu TC, Vachharajani N, Chapman WC, Brunt EM: SALL4 immunoreactivity predicts prognosis in western hepatocellular carcinoma patients but is a rare event: a study of 236 cases. Am J Surg Pathol 2014, 38: 966-972. doi:10.1097/PAS.0000000000000218
Article
Google Scholar
Ma Y, Cui W, Yang J, Qu J, Di C, Amin HM, Lai R, Ritz J, Krause DS, Chai L: SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood 2006, 108: 2726-2735. 10.1182/blood-2006-02-001594
Article
Google Scholar
Miettinen M, Wang Z, McCue PA, Sarlomo-Rikala M, Rys J, Biernat W, Lasota J, Lee YS: SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases. Am J Surg Pathol 2014, 38: 410-420. doi:10.1097/PAS.0000000000000116
Article
Google Scholar
Oikawa T, Kamiya A, Kakinuma S, Zeniya M, Nishinakamura R, Tajiri H, Nakauchi H: Sall4 regulates cell fate decision in fetal hepatic stem/progenitor cells. Gastroenterology 2009, 136: 1000-1011. doi:10.1053/j.gastro.2008.11.018
Article
Google Scholar
Oikawa T, Kamiya A, Zeniya M, Chikada H, Hyuck AD, Yamazaki Y, Wauthier E, Tajiri H, Miller LD, Wang XW, Reid LM, Nakauchi H: Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology 2013, 57: 1469-1483. doi:10.1002/hep.26159
Article
Google Scholar
Oishi N, Yamashita T, Kaneko S: Molecular biology of liver cancer stem cells. Liver Cancer 2014, 3: 71-84. doi:10.1159/000343863
Article
Google Scholar
Rao S, Zhen S, Roumiantsev S, McDonald LT, Yuan GC, Orkin SH: Differential roles of Sall4 isoforms in embryonic stem cell pluripotency. Mol Cell Biol 2010, 30: 5364-5380. doi:10.1128/MCB.00419-10
Article
Google Scholar
Rountree CB, Mishra L, Willenbring H: Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology 2012, 55: 298-306. doi:10.1002/hep.24762
Article
Google Scholar
Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH: Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol 2010, 34: 1630-1636. doi:10.1097/PAS.0b013e3181f31caa
Google Scholar
Theise ND, Curado MP, Franceschi S, Hytiroglou P, Kudo M, Park YN, Sakamoto M, Torbenson M, Wee A: Hepatocellular carcinoma. In WHO Classification of Tumours of the Digestive System. Edited by: Bosman FT, Carneiro F, Hruban RH, Theise ND. Lyon: IARC; 2010.
Google Scholar
Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, Fukayama M: SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol 2010, 34: 533-540. doi:10.1097/PAS.0b013e3181d1dcdd
Article
Google Scholar
Wu JC, Huang YH, Chau GY, Su CW, Lai CR, Lee PC, Huo TI, Sheen IJ, Lee SD, Lui WY: Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 2009, 51: 890-897. doi:10.1016/j.jhep.2009.07.009
Article
Google Scholar
Yang J, Chai L, Fowles TC, Alipio Z, Xu D, Fink LM, Ward DC, Ma Y: Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci U S A 2008, 105: 19756-19761. doi:10.1073/pnas.0809321105
Article
Google Scholar
Yong KJ, Gao C, Lim JS, Yan B, Yang H, Dimitrov T, Kawasaki A, Ong CW, Wong KF, Lee S, Ravikumar S, Srivastava S, Tian X, Poon RT, Fan ST, Luk JM, Dan YY, Salto-Tellez M, Chai L, Tenen DG: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med 2013, 368: 2266-2276. doi:10.1056/NEJMoa1300297
Article
Google Scholar
Zeng SS, Yamashita T, Kondo M, Nio K, Hayashi T, Hara Y, Nomura Y, Yoshida M, Hayashi T, Oishi N, Ikeda H, Honda M, Kaneko S: The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. J Hepatol 2014, 60: 127-134. doi:10.1016/j.jhep.2013.08.024
Article
Google Scholar
Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, Soh BS, Lou Y, Yang J, Ma Y, Chai L, Ng HH, Lufkin T, Robson P, Lim B: Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 2006, 8: 1114-1123. 10.1038/ncb1481
Article
Google Scholar